Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?

Ítems similars

• Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
  per: Kasimir-Bauer, Sabine, et al.
  Publicat: (2016)
• Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
  per: Fehm, Tanja, et al.
  Publicat: (2009)
• Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients
  per: Bittner, Ann‐Kathrin, et al.
  Publicat: (2020)
• Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer
  per: Kasimir-Bauer, Sabine, et al.
  Publicat: (2020)
• Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX(®), clinicopathological markers and tumor cell dissemination in the blood and bone marrow
  per: AKTAS, BAHRIYE, et al.
  Publicat: (2013)